A detailed history of Hbc Financial Services, Pllc transactions in Abb Vie Inc. stock. As of the latest transaction made, Hbc Financial Services, Pllc holds 1,388 shares of ABBV stock, worth $248,729. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,388
Previous 1,371 1.24%
Holding current value
$248,729
Previous $249,000 12.05%
% of portfolio
0.17%
Previous 0.16%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $2,785 - $3,388
17 Added 1.24%
1,388 $279,000
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $155,099 - $181,121
1,002 Added 271.54%
1,371 $249,000
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $159 - $182
1 Added 0.27%
369 $59,000
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $275 - $309
2 Added 0.55%
368 $57,000
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $267 - $309
2 Added 0.55%
366 $54,000
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $132 - $164
1 Added 0.28%
364 $49,000
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $289 - $333
2 Added 0.55%
363 $58,000
Q4 2022

Jan 18, 2023

BUY
$138.31 - $165.87 $138 - $165
1 Added 0.28%
361 $59,000
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $268 - $307
2 Added 0.56%
360 $48,000
Q2 2022

Jul 22, 2022

SELL
$137.62 - $174.96 $34,267 - $43,565
-249 Reduced 41.02%
358 $54,000
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $51,340 - $63,698
-389 Reduced 39.06%
607 $98,000
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $13,106 - $16,583
122 Added 13.96%
996 $134,000
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $2,340 - $2,657
22 Added 2.58%
874 $96,000
Q2 2021

Aug 02, 2021

SELL
$105.21 - $117.21 $20,936 - $23,324
-199 Reduced 18.93%
852 $98,000
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $1,841 - $2,027
-18 Reduced 1.68%
1,051 $113,000
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $1,931 - $2,608
-24 Reduced 2.2%
1,069 $114,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $6,615 - $7,763
77 Added 7.58%
1,093 $104,000
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $2,054 - $2,749
-28 Reduced 2.68%
1,016 $102,000
Q1 2020

May 04, 2020

SELL
$64.5 - $97.79 $6,385 - $9,681
-99 Reduced 8.66%
1,044 $76,000
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $82,444 - $103,155
1,143 New
1,143 $102,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hbc Financial Services, Pllc Portfolio

Follow Hbc Financial Services, Pllc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbc Financial Services, Pllc, based on Form 13F filings with the SEC.

News

Stay updated on Hbc Financial Services, Pllc with notifications on news.